0      0

Regenerative Medicine: Updates on Blood-based & Cell-based Therapies

‐ Mar 2, 2023 10:45am

  • Platelet Rich Plasma (PRP)
  • Regulation of biologics by Center for Biologics Evaluation and Research (CBER) & U.S. Food and Drug Administration (FDA)
  • FDA 351 vs 361: Ensuring safety & Compliance
  • Influence disease process through neuroimmune modulation


You must be logged in and own this session in order to post comments.